Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 71Neoplasms 70Lung Neoplasms 29Prostatic Neoplasms 26Head and Neck Neoplasms 22Colorectal Neoplasms 19Uterine Cervical Neoplasms 17Ovarian Neoplasms 13Neoplasm Metastasis 13Motor Activity 13Fatigue 11Endometrial Neoplasms 11Colonic Neoplasms 11Brain Neoplasms 11Pain 10Carcinoma, Non-Small-Cell Lung 10Multiple Myeloma 9Melanoma 9Rectal Neoplasms 8Leukemia 8Gastrointestinal Neoplasms 8Smoking Cessation 7Pancreatic Neoplasms 7Lymphoma 7Depression 7cyclopia sequence 6Esophageal Neoplasms 6Carcinoma, Renal Cell 6Advanced Cancer 6Uterine Neoplasms 5

Interventions

Celecoxib 4Surveys and Questionnaires 2Sulindac 2Erlotinib Hydrochloride 2Endoscopy 2Eflornithine 2Curcumin 2Biopsy 2guselkumab 1Ursodeoxycholic Acid 1Suppositories 1Sirolimus 1Sigmoidoscopy 1Metformin 1Lithium Carbonate 1Gastroscopy 1Endoscopy, Digestive System 1Eicosapentaenoic Acid 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Adenomatous Polyposis Coli × Surveys and Questionnaires × Clear all
NCT00525655 2021-03-23

Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)

M.D. Anderson Cancer Center

Phase NA Completed
31 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT00033371 2020-09-29

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Completed
205 enrolled 16 charts
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡